Loading…

Coupling several spectral manipulations with isosbestic approach to resolve overlapped spectra for concurrent analysis of lamivudine/tenofovir combination: Evaluating environmental sustainability

Acquired immunodeficiency syndrome (AIDS) is a chronic disease caused by the human immunodeficiency virus (HIV), which can severely damage the immune system. Recently, lamivudine (LAM) and tenofovir disoproxil fumarate (TDF) were co-formulated for the management of (AIDS). This work proposes three n...

Full description

Saved in:
Bibliographic Details
Published in:Sustainable chemistry and pharmacy 2024-10, Vol.41, p.101709, Article 101709
Main Authors: Khashaba, Bardees Abdelmonem, Ibrahim, Elsayed A., Hadad, Ghada M., Fawzy, Michael Gamal
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acquired immunodeficiency syndrome (AIDS) is a chronic disease caused by the human immunodeficiency virus (HIV), which can severely damage the immune system. Recently, lamivudine (LAM) and tenofovir disoproxil fumarate (TDF) were co-formulated for the management of (AIDS). This work proposes three new UV spectrophotometric approaches based on the isosbestic point, namely: absorption subtraction method (AS), amplitude modulation method (AM) and amplitude summation method (A-Sum). The (AS) approach is based on the absorption factor method, and the two drugs can be determined at the isosbestic point in the range's zero order absorption spectra (224 nm). The (AM) method is utilizing normalized spectrum of LAM (1 μg/mL) as a divisor spectrum. After division, LAM and TDF can be determined at the isosbestic point that remained in the obtained ratio spectra at the same point even after division (224 nm). In (A-Sum) method, first order derivatization is done and the two drugs can be detected at the isosbestic point (276 nm) by using amplitude factor. The linear ranges for LAM and TDF were 5–30 μg/mL and 10–50 μg/mL, respectively. The limits of detection for LAM and TDF were 0.71–0.90 μg/mL and 0.56–1.09 μg/mL, respectively, indicating the sensitivity of these approaches. The two drugs were determined at the isospestic point without the requirement for a supplemental technique using the relevant unified regression equation. All methods were found to be accurate, repeatable, and selective based on ICH recommendations for linearity, accuracy, precision, and selectivity. The obtained results were statistically compared to the reported HPLC methods for LAM and TDF, which revealed no significant. [Display omitted] •Spectrophotometric methods for simultaneous determination of LAM/TDF mixture without need of prior separation.•Application of isosbestic point for resolving overlapped spectra.•LAM/TDF mixture was analyzed in pure form, laboratory prepared mixture and dosage form.•Assessment of the greenness of the analytical methods by GAPI and AGREE metrics.•The developed spectrophotometric methods were simple, accurate and precise.
ISSN:2352-5541
2352-5541
DOI:10.1016/j.scp.2024.101709